Serum Endostatin Is a Novel Marker for COPD Associated with Lower Lung Function, Exacerbation and Systemic Inflammation

References

• VogelmeierCF, CrinerGJ, MartinezFJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD Executive Summary. Am J Respir Crit Care Med. 2017;195:557–582. doi:10.1164/rccm.201701-0218PP28128970
   PubMed Web of Science ®Google Scholar
• LozanoR, NaghaviM, ForemanK, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of disease study 2010. Lancet. 2012;380:2095–2128. doi:10.1016/S0140-6736(12)61728-023245604
   PubMed Web of Science ®Google Scholar
• AgustiAG, NogueraA, SauledaJ, et al. Systemic effects of chronic obstructive pulmonary disease. Eur Respir J. 2003;21:347–360. doi:10.1183/09031936.03.0040570312608452
   PubMed Web of Science ®Google Scholar
• PeinadoVI, BarberaJA, RamirezJ, et al. Endothelial dysfunction in pulmonary arteries of patients with mild COPD. Am J Physiol. 1998;274:L908–L913. doi:10.1152/ajplung.1998.274.6.L9089609729
   PubMed Web of Science ®Google Scholar
• EidAA, IonescuAA, NixonLS, et al. Inflammatory response and body composition in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001;164:1414–1418. doi:10.1164/ajrccm.164.8.200810911704588
   PubMed Web of Science ®Google Scholar
• PihtiliA, BingolZ, KiyanE. Serum endocan levels in patients with stable COPD. Int J Chron Obstruct Pulmon Dis. 2018;13:3367–3372. doi:10.2147/COPD30410323
   PubMed Web of Science ®Google Scholar
• O’reillyMS, BoehmT, ShingY, et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell. 1997;88:277–285. doi:10.1016/S0092-8674(00)81848-69008168
   PubMed Web of Science ®Google Scholar
• WickstromSA, VeikkolaT, RehnM, et al. Endostatin-induced modulation of plasminogen activation with concomitant loss of focal adhesions and actin stress fibers in cultured human endothelial cells. Cancer Res. 2001;61:6511–6516.11522648
   PubMed Web of Science ®Google Scholar
• AbdollahiA, HahnfeldtP, MaerckerC, et al. Endostatin’s antiangiogenic signaling network. Mol Cell. 2004;13:649–663. doi:10.1016/S1097-2765(04)00102-915023336
   PubMed Web of Science ®Google Scholar
• SchmidtA, AddicksK, BlochW. Opposite effects of endostatin on different endothelial cells. Cancer Biol Ther. 2004;3:1162–1166; discussion 1167–1168. doi:10.4161/cbt.3.11.1219
   PubMed Web of Science ®Google Scholar
• RugeT, CarlssonAC, LarssonTE, et al. Endostatin level is associated with kidney injury in the elderly: findings from two community-based cohorts. Am J Nephrol. 2014;40:417–424. doi:10.1159/00036907625401956
   PubMed Web of Science ®Google Scholar
• HebbarM, PeyratJP, HornezL, et al. Increased concentrations of the circulating angiogenesis inhibitor endostatin in patients with systemic sclerosis. Arthritis Rheum. 2000;43:889–893. doi:10.1002/1529-0131(200004)43:4<889::AID-ANR21>3.0.CO;2-510765935
   PubMed Web of Science ®Google Scholar
• FunatsuH, YamashitaH, NomaH, et al. Stimulation and inhibition of angiogenesis in diabetic retinopathy. Jpn J Ophthalmol. 2001;45:577–584. doi:10.1016/S0021-5155(01)00420-811754898
   PubMed Web of Science ®Google Scholar
• DamicoR, KolbTM, ValeraL, et al. Serum endostatin is a genetically determined predictor of survival in pulmonary arterial hypertension. Am J Respir Crit Care Med. 2015;191:208–218. doi:10.1164/rccm.201409-1742OC25489667
   PubMed Web of Science ®Google Scholar
• KanazawaH, HirataK, YoshikawaJ. Imbalance between vascular endothelial growth factor and endostatin in emphysema. Eur Respir J. 2003;22:609–612. doi:10.1183/09031936.03.0003040314582912
   PubMed Web of Science ®Google Scholar
• FolkmanJ, KlagsbrunM. Angiogenic factors. Science. 1987;235:442–447. doi:10.1126/science.24326642432664
   PubMed Web of Science ®Google Scholar
• FerraraN, Davis-SmythT. The biology of vascular endothelial growth factor. Endocr Rev. 1997;18:4–25. doi:10.1210/edrv.18.1.02879034784
   PubMed Web of Science ®Google Scholar
• AlagappanVK, De BoerWI, MisraVK, MooiWJ, SharmaHS. Angiogenesis and vascular remodeling in chronic airway diseases. Cell Biochem Biophys. 2013;67:219–234. doi:10.1007/s12013-013-9713-623975597
   PubMed Web of Science ®Google Scholar
• De BoerWI, HauCM, Van SchadewijkA, et al. Expression of epidermal growth factors and their receptors in the bronchial epithelium of subjects with chronic obstructive pulmonary disease. Am J Clin Pathol. 2006;125:184–192. doi:10.1309/W1AXKGT7UA37X25716393673
   PubMed Web of Science ®Google Scholar
• GanesanS, UngerBL, ComstockAT, et al. Aberrantly activated EGFR contributes to enhanced IL-8 expression in COPD airways epithelial cells via regulation of nuclear FoxO3A. Thorax. 2013;68:131–141. doi:10.1136/thoraxjnl-2012-20171923099361
   PubMed Web of Science ®Google Scholar
• MeyerN, AkdisCA. Vascular endothelial growth factor as a key inducer of angiogenesis in the asthmatic airways. Curr Allergy Asthma Rep. 2013;13:1–9. doi:10.1007/s11882-012-0317-923076420
   PubMed Web of Science ®Google Scholar
• KranenburgAR, De BoerWI, AlagappanVK, SterkPJ, SharmaHS. Enhanced bronchial expression of vascular endothelial growth factor and receptors (Flk-1 and Flt-1) in patients with chronic obstructive pulmonary disease. Thorax. 2005;60:106–113. doi:10.1136/thx.2004.02398615681497
   PubMed Web of Science ®Google Scholar
• Farid HosseiniR, Jabbari AzadF, YousefzadehH, et al. Serum levels of vascular endothelial growth factor in chronic obstructive pulmonary disease. Med J Islam Repub Iran. 2014;28:85.25664286
   PubMedGoogle Scholar
• HajitouA, GrignetC, DevyL, et al. The antitumoral effect of endostatin and angiostatin is associated with a down-regulation of vascular endothelial growth factor expression in tumor cells. FASEB J. 2002;16:1802–1804.12354694
   PubMed Web of Science ®Google Scholar
• NagashimaM, AsanoG, YoshinoS. Imbalance in production between vascular endothelial growth factor and endostatin in patients with rheumatoid arthritis. J Rheumatol. 2000;27:2339–2342.11036826
   PubMed Web of Science ®Google Scholar
• Kobusiak-ProkopowiczM, Jolda-MydlowskaB, GrzebieniakT, PoczatekK, MysiakA. Expression of proinflammatory factors, proangiogenic factors and endostatin in patients with heart failure and different grades of collateral circulation development. Adv Clin Exp Med. 2015;24:987–994. doi:10.17219/acem/3381126771970
   PubMed Web of Science ®Google Scholar
• KanbayM, AfsarB, SiriopolD, et al. Endostatin in chronic kidney disease: associations with inflammation, vascular abnormalities, cardiovascular events and survival. Eur J Intern Med. 2016;33:81–87. doi:10.1016/j.ejim.2016.06.03327394925
   PubMed Web of Science ®Google Scholar
• KoyamaS, SatoE, TsukadairaA, et al. Vascular endothelial growth factor mRNA and protein expression in airway epithelial cell lines in vitro. Eur Respir J. 2002;20:1449–1456. doi:10.1183/09031936.02.0008980212503703
   PubMed Web of Science ®Google Scholar
• AraoT, TakabatakeN, SataM, et al. In vivo evidence of endothelial injury in chronic obstructive pulmonary disease by lung scintigraphic assessment of (123)I-metaiodobenzylguanidine. J Nucl Med. 2003;44:1747–1754.14602855
   PubMed Web of Science ®Google Scholar
• KasaharaY, TuderRM, Taraseviciene-StewartL, et al. Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. J Clin Invest. 2000;106:1311–1319. doi:10.1172/JCI1025911104784
   PubMed Web of Science ®Google Scholar
• LinCH, ChenJ, ZimanB, et al. Endostatin and kidney fibrosis in aging: a case for antagonistic pleiotropy? Am J Physiol Heart Circ Physiol. 2014;306:H1692–H1699. doi:10.1152/ajplegacy.1975.229.3.57024727495
   PubMed Web of Science ®Google Scholar
• KimYM, HwangS, KimYM, et al. Endostatin blocks vascular endothelial growth factor-mediated signaling via direct interaction with KDR/Flk-1. J Biol Chem. 2002;277:27872–27879. doi:10.1074/jbc.M20277120012029087
   PubMed Web of Science ®Google Scholar
• DecramerM, De BenedettoF, Del PonteA, MarinariS. Systemic effects of COPD. Respir Med. 2005;99(Suppl B):S3–10. doi:10.1016/j.rmed.2005.09.01016219454
   PubMed Web of Science ®Google Scholar